Yi Ning

Prof. Yi Ning


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2019 in Luminescence
Verified
Journal Article
Closed access
PDF file
QHQizhi He
Qizhi He
HLHuaiqing Luo
Huaiqing Luo
LCLingli Chen
Lingli Chen
JDJun Dong
Jun Dong
KCKeke Chen
Keke Chen
YNYi Ning
Yi Ning

4 April 2025 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
JFJingmin Fu
Jingmin Fu
ZLZhuolin Liu
Zhuolin Liu
ZFZhiying Feng
Zhiying Feng
JHJiawang Huang
Jiawang Huang
JSJianing Shi
Jianing Shi
LLLing Li
Ling Li
Acute lung injury (ALI) is a severe respiratory disease accompanied by diffuse inflammatory responses induced by various clinical causes. Many fresh medicinal plants have shown better efficacy than their dried forms in preventing and treating diseases like inflammation. As a classical Chinese herb, platycodon grandiflorum (PG) has been demonstrated effective in treating pneumonia, but most of previous studies focused on the efficacy of processed or dried PG formats, while the specific benefits of its fresh form are still underexplored. Exosome-like nanoparticles derived from medicinal plants are expected to point out an important direction for exploring the material basis and mechanism of this fresh herbal medicine. The fresh form of PG could effectively improve ALI induced by lipopolysaccharide (LPS), relieve lung histopathological injury and weight loss, and reduce levels of inflammatory factors in mice, exhibiting better efficacy than dried PG in the treatment of ALI. Further extraction and purification of PG exosome-like nanoparticles (PGLNs) demonstrated that PGLNs had good biocompatibility, with characteristics consistent with general exosome-like nanoparticles. Besides, proteomic analysis indicated that PGLNs were rich in a variety of proteins. Animal experiments showed that PGLNs improved the pathological changes in LPS-induced lung tissues, inhibited the expression of inflammatory factors and promoted the expression of anti-inflammatory factors, and exerted a regulatory effect on the polarization of lung macrophages. Cell experiments further confirmed that PGLNs could be effectively taken up by RAW264.7 cells and repolarize M1 macrophages into M2 type, therefore reducing the secretion of harmful cytokines. Moreover, non-targeted metabolomics analysis reveals that PGLNs reduce inflammation and control macrophage polarization in a manner closely linked to pathways including glycolysis and lipid metabolism, highlighting a potential mechanism by which PGLNs protect the lungs from inflammatory damage like ALI. Fresh PG has better anti-inflammatory and repair effects than its dried form. As one of the most effective active substances in fresh PG, PGLNs may regulate macrophage inflammation and polarization by regulating metabolic pathways including lipid metabolism and glycolysis, so as to reduce inflammation and repair lung injury.

17 July 2024 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
XWXiaoqi Wang
Xiaoqi Wang
CCChunjing Chen
Chunjing Chen
JHJue Hu
Jue Hu
CLChang Liu
Chang Liu
YNYi Ning
Yi Ning
FLFangguo Lu
Fangguo Lu
Biofilms, intricate microbial communities that attach to surfaces, especially medical devices, form an exopolysaccharide matrix, which enables bacteria to resist environmental pressures and conventional antimicrobial agents, leading to the emergence of multi-drug resistance. Biofilm-related infections associated with medical devices are a significant public health threat, compromising device performance. Therefore, developing effective methods for supervising and managing biofilm growth is imperative. This in-depth review presents a systematic overview of strategies for monitoring and controlling bacterial biofilms. We first outline the biofilm creation process and its regulatory mechanisms. The discussion then progresses to advancements in biosensors for biofilm detection and diverse treatment strategies. Lastly, this review examines the obstacles and new perspectives associated with this domain to facilitate the advancement of innovative monitoring and control solutions. These advancements are vital in combating the spread of multi drug-resistant bacteria and mitigating public health risks associated with infections from biofilm formation on medical instruments.

11 April 2023 in Talanta
Verified
Journal Article
Closed access
SLShiwu Liu
Shiwu Liu
SCShanquan Chen
Shanquan Chen
LTLongzhi Tian
Longzhi Tian
QHQizhi He
Qizhi He
XWXiaoqi Wang
Xiaoqi Wang
YNYi Ning
Yi Ning

1 October 2021 in Analytical Letters
Verified
Journal Article
Closed access
QHQizhi He
Qizhi He
SMShuheng Ma
Shuheng Ma
JWJingya Wang
Jingya Wang
KCKeke Chen
Keke Chen
JDJun Dong
Jun Dong
YNYi Ning
Yi Ning
A convenient and highly sensitive bioassay employing graphene oxide (GO) as a nanocarrier and nicking enzyme (Nb.BbvC I)-assisted signal amplification was developed to detect Pseudomonas aeruginosa. Furthermore, the assay employed a DNA probe with a capture probe (CP) and a help probe (HP), which were designed to bind the target and signal probe (SP), respectively. In the absence of the target, the SP did not bind to the HP due to steric effects. Consequently, the fluorescence of carboxyfluorescein (FAM) was quenched by the black hole quenching group (BHQ). The CP specifically recognized the introduced target, which opened the HP that was bound to the SP. Nb.BbvC I cleaved the formed nicking site, which restored the fluorescence and simultaneously released the HP for the next round of reaction. The target densities, which ranged from 10 to 107 colony-forming units (CFU) mL−1, and the fluorescence intensity had a linear relationship. The limit of detection (LOD) under the optimal conditions was 5 CFU mL−1. Moreover, this bioassay performed well in the analysis of water samples. These results demonstrate that this method is highly specific and sensitive for determining P. aeruginosa and is promising for the clinical diagnosis of infectious diseases.

24 May 2023 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
SLShiwu Liu
Shiwu Liu
LTLongzhi Tian
Longzhi Tian
QHQizhi He
Qizhi He
XWXiaoqi Wang
Xiaoqi Wang
JHJue Hu
Jue Hu
YNYi Ning
Yi Ning
Schematic representation of the graphene oxide-based fluorometric bioassay for determination of agrB gene transcription in MRSA by coupling exonuclease III-assisted target recycling and hybridization chain reaction.